Multimodal Somatostatin Receptor Theranostics Using [(64)Cu]Cu-/[(177)Lu]Lu-DOTA-(Tyr(3))octreotate and AN-238 in a Mouse Pheochromocytoma Model

Affiliations

• ¹ 1. Dept. of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany;
• ² 2. Institute for Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany;
• ³ 3. University Cancer Center, Tumorimmunology, Technische Universität Dresden, Dresden, Germany;
• ⁴ 1. Dept. of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany;; 3. University Cancer Center, Tumorimmunology, Technische Universität Dresden, Dresden, Germany;
• ⁵ 4. Dept. of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
• ⁶ 5. VA Medical Center Miami FL and Dept. of Pathology and Medicine, Div. of Endocrinology and Hematology-Oncology and Sylvester Comprehensive Cancer Center, University of Miami Miller School of Medicine, Miami FL, USA.
• ⁷ 2. Institute for Clinical Chemistry and Laboratory Medicine, Technische Universität Dresden, Dresden, Germany;; 4. Dept. of Medicine III, University Hospital Carl Gustav Carus, Dresden, Germany.
• ⁸ 1. Dept. of Radiopharmaceutical and Chemical Biology, Institute of Radiopharmaceutical Cancer Research, Helmholtz-Zentrum Dresden-Rossendorf, Dresden, Germany;; 6. Dept. of Chemistry and Food Chemistry, Technische Universität Dresden, Dresden, Germany;
• ⁹ 7. Paul Langerhans Institute Dresden of the Helmholtz Center Munich at the University Hospital and faculty of Medicine, Technische Universität Dresden, Dresden, Germany;; 8. German Center for Diabetes Research e.V., Neuherberg, Germany.